(19)
(11) EP 2 004 161 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
17.04.2013 Bulletin 2013/16

(45) Mention of the grant of the patent:
23.05.2012 Bulletin 2012/21

(21) Application number: 07727920.6

(22) Date of filing: 10.04.2007
(51) International Patent Classification (IPC): 
A61K 31/07(2006.01)
A61K 31/352(2006.01)
A61P 17/00(2006.01)
 A61K 31/202(2006.01)
A61K 31/375(2006.01)
(86) International application number:
PCT/EP2007/053452
(87) International publication number:
WO 2007/116052 (18.10.2007 Gazette 2007/42)

(54)

ORAL COMPOSITION COMPRISING DHA AND GENISTEIN FOR ENHANCING SKIN PROPERTIES

ORALE ZUSAMMENSETZUNG MIT DHA UND GENISTEIN ZUR VERBESSERUNG DER HAUTEIGENSCHAFTEN

COMPOSITION ORALE COMPRENANT DE L'ADH ET DE LA GÉNISTÉINE POUR AMÉLIORER L'APPARANCE CUTANÉ

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

(30) Priority: 12.04.2006 EP 06252020
12.02.2007 EP 07102128

(43) Date of publication of application:
24.12.2008 Bulletin 2008/52

(73) Proprietors:
  • Unilever PLC
    London EC4Y 0DY (GB)
    Designated Contracting States:
    CY GB IE MT 
  • Unilever N.V.
    3013 AL Rotterdam (NL)
    Designated Contracting States:
    AT BE BG CH CZ DE DK EE ES FI FR GR HU IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR 

(72) Inventors:
  • CASEY, John
    Bedford Bedfordshire MK44 1LQ (GB)
  • JENKINS, Gail
    Bedford Bedfordshire MK44 1LQ (GB)
  • WAINWRIGHT, Linda, Jane
    Bedford Bedfordshire MK44 1LQ (GB)

(74) Representative: Acham, Nicholas Clive 
Unilever Patent Group Colworth House
Sharnbrook Bedford MK44 1LQ
Sharnbrook Bedford MK44 1LQ (GB)


(56) References cited: : 
WO-A-2006/056293
US-B1- 6 335 038
 US-A1- 2004 082 523
   
  • RHODES LESLEY E ET AL: "Dietary fish-oil supplementation in humans reduces UVB-erythemal sensitivity but increases epidermal lipid peroxidation" JOURNAL OF INVESTIGATIVE DERMATOLOGY, vol. 103, no. 2, 1994, pages 151-154, XP009069139 ISSN: 0022-202X
  • RHODES LESLEY E ET AL: "Dietary fish oil reduces basal and ultraviolet B-generated PGE-2 levels in skin and increases the threshold to provocation of polymorphic light eruption" JOURNAL OF INVESTIGATIVE DERMATOLOGY, vol. 105, no. 4, 1995, pages 532-535, XP009069138 ISSN: 0022-202X
  • WEI HUACHEN ET AL: "Isoflavone genistein: Photoprotection and clinical implications in dermatology." JOURNAL OF NUTRITION, vol. 133, no. 11S-I, November 2003 (2003-11), pages 3811S-3819S, XP009068868 & INTERNATIONAL RESEARCH CONFERENCE ON FOOD, NUTRITION, AND CANCER; WASHINGTON DC, USA; JULY 17-18, 2003 ISSN: 0022-3166
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).